Correlation Between Fonar and Champions Oncology
Can any of the company-specific risk be diversified away by investing in both Fonar and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fonar and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fonar and Champions Oncology, you can compare the effects of market volatilities on Fonar and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fonar with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fonar and Champions Oncology.
Diversification Opportunities for Fonar and Champions Oncology
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Fonar and Champions is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Fonar and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Fonar is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fonar are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Fonar i.e., Fonar and Champions Oncology go up and down completely randomly.
Pair Corralation between Fonar and Champions Oncology
Given the investment horizon of 90 days Fonar is expected to generate 2.82 times less return on investment than Champions Oncology. But when comparing it to its historical volatility, Fonar is 1.54 times less risky than Champions Oncology. It trades about 0.0 of its potential returns per unit of risk. Champions Oncology is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 538.00 in Champions Oncology on August 31, 2024 and sell it today you would lose (86.00) from holding Champions Oncology or give up 15.99% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Fonar vs. Champions Oncology
Performance |
| Timeline |
| Fonar |
| Champions Oncology |
Fonar and Champions Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fonar and Champions Oncology
The main advantage of trading using opposite Fonar and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fonar position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.| Fonar vs. Burning Rock Biotech | Fonar vs. Sera Prognostics | Fonar vs. Exagen Inc | Fonar vs. Castle Biosciences |
| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |